EVELYN KEATON: Open Payments
NPI 1306942529 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$439 in 6 payments from 6 companies in 2025. Trend: 2023 $1,008 · 2024 $924 · 2025 $439
Food & beverage: $382Education: $57
| Company | Payments | Amount |
|---|---|---|
| Optinose US, Inc. | 1 | $122 |
| Regeneron Healthcare Solutions, Inc. | 1 | $106 |
| GlaxoSmithKline, LLC. | 1 | $60 |
| Smith+Nephew, Inc. | 1 | $59 |
| SANOFI-AVENTIS U.S. LLC | 1 | $57 |
| Novartis Pharmaceuticals Corporation | 1 | $35 |
Products named: DUPIXENT, Xhance, NUCALA, TULA.
Industry payments across CA — which companies pay providers there.
